SpringWorks Therapeutics Inc (NASDAQ:SWTX) price on Thursday, February 27, fall -1.35% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $53.41.
A look at the stock’s price movement, the close in the last trading session was $54.14. Turning to its 52-week performance, $62.00 and $28.21 were the 52-week high and 52-week low respectively. Overall, SWTX moved 48.82% over the past month.
SpringWorks Therapeutics Inc’s market cap currently stands at around $4.00 billion, with investors looking forward to this quarter’s earnings report slated for in March.
Analysts have a consensus estimate of 66.93M for the company’s revenue for the quarter, with a low and high estimate of 66.22M and 68.1M respectively. The average forecast suggests up to a 218.64% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 349.44M, representing a 82.39% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that SWTX is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend SWTX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
SWTX’s current price about 6.58% and 26.82% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 59.14, while 7-day volatility ratio is 3.96% and 7.53% in the 30-day chart. Further, SpringWorks Therapeutics Inc (SWTX) has a beta value of 0.77, and an average true range (ATR) of 3.35. Analysts have given the company’s stock an average 52-week price target of $78, forecast between a low of $78 and high of $78. Looking at the price targets, the low is -46.04% off current price level while to achieve the yearly target high, price needs to move -46.04%. Nonetheless, investors will most likely welcome a -46.04% jump to $78 which is the analysts’ median price.
If we refocus on SpringWorks Therapeutics Inc (NASDAQ:SWTX), historical trading data shows that trading volumes averaged 2.03 million over the past 3 months. The company’s latest data on shares outstanding shows there are 74.40 million shares.
The 6.33% of SpringWorks Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 106.12% of the company’s shares. Current price change has pushed the stock 47.83% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SWTX stock continues to rise going into the next quarter.
